Great opportunity supported by @PIDSociety to present your stewardship-related research at the pediatric ASP Conference! Please re-tweet and consider applying!
@JasonGNewland@RebeccaSame@CHOP_ID
Face-off!!!! Come see me and @RachelWattier duke it out over antibacterial prophylaxis for kids with leukemia next week at the @PIDSociety ASP meeting.
Interested in 3 days dedicated to improving antimicrobials use for children in all settings or help in starting/improving your own ASP? Register (in person or virtual) for the Annual Int'l Pediatric Antimicrobial Stewardship Conference 5/31-6/2 in St Louis https://t.co/Mni6OD3VNb
Registration (in person and virtual) for the Annual International Pediatric Antimicrobial Stewardship Conference remains open. Join us for 3 days dedicated to improving antimicrobials use for children in all settings and helping start and improve ASP.
https://t.co/Mni6OD3VNb
This nation was built on peaceful protest. No elected official should lose their job simply for raising their voice – especially when they’re doing it on behalf of our children.
“Though #antibiotic overuse may have led us into this shortage, better antibiotic stewardship may just lead us out of it,” @drkatielockwood and @RebeccaSame write of the current shortage of #amoxicillin. https://t.co/LkdPUvD4rr
Registration for the 13th Annual International Pediatric Antimicrobial Stewardship Conference (May 31-June 2 in St. Louis and virtual) is now open. All conference info, including abstract submission, is available at https://t.co/Mni6OD3VNb
“Though #antibiotic overuse may have led us into this shortage, better antibiotic stewardship may just lead us out of it,” @drkatielockwood and @RebeccaSame write of the current shortage of #amoxicillin. https://t.co/RHmREWambU
One of the biggest public health threat is antibiotic resistance. This is especially troublesome after the COVID-19 pandemic, deciding when is it appropriate to use antibiotics? (1/7)
Let’s start the week with a quizzo to test your knowledge on some concerning side effects and ways YOU can become a better steward! ASP monitors IV-to-PO switch opportunities, assesses beta-lactam allergies, promotes appropriate duration of therapy and so much more!#USAAW22 (1/4)
With RSV, influenza and Community-Acquired Pneumonia (CAP) on the rise, it can be difficult to decide when and what antibiotics to use. Rest assured, a macrolide is usually not needed in our pediatric patients aged 5 or less. Check out our tip for more information. (2/2)

Celebrate #AntibioticAwarenessWeek with us as our Antimicrobial Stewardship Program (ASP) team takes over! Let’s start with our first ASP Tip of the Month! (1/2)
@WendyHassonMD Someone handed out skittles at a Halloween event and my four year old fished them out of her bag and handed them to me, saying “here you go! These are a choking hazard!” #funmom
"Experience around the world has demonstrated that restricting access to legal abortion care does not substantially reduce the number of procedures, but it dramatically reduces the number of *safe* procedures, resulting in increased morbidity and mortality."
The just-announced U.S. Supreme Court decision in Dobbs v. Jackson Women’s Health Organization represents a stunning reversal of precedent that inserts government into the personal lives and health care of Americans. https://t.co/yB5WRMlXso
@eamonsees shows us how to bring nurses into antimicrobial stewardship.
1️⃣ Include stewardship in nursing scope as a patient and med safety issue.
2️⃣ Provide tools, education, and culture that empowers RNs to feel confident speaking up about abx concerns.
#PedsASP2022
Sharon Tsay gave a very informative update on @CDC_AR stewardship activities.
Interesting trends in prescribing during COVID. Spoiler alert—that initial drop in outpatient abx prescribing didn’t last, but lots of work being done to optimize abx use across settings. #PedsASP2022
Lots of variability in practice, but some consensus to use vanc empirically, for rule outs, and CNS infection.
Consider alternatives (dapto, ceftaroline, linezolid) for children with complicated MRSA infections, risk factors for poor outcomes, or toxicity.
#PedsASP2022
Newer agents show promise for 📉 toxicity and *maybe* 📈efficacy, but data are still lacking in a lot of areas, especially dosing in children for some infections, ie bacteremia and 🧠 for ceftaroline. And jury is still out on risk of resistance. #PedsASP2022